Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration. (Q53315137)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2017

Language	Label	Description	Also known as
English	Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration.	scientific article published in May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration. (English)

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

1 reference

based on heuristic

inferred from title

author name string

Thiago Cabral

1

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Luiz H Lima

2

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Júlia Polido

3

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Jimmy Duong

4

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Érika Okuda

5

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Akiyoshi Oshima

6

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Pedro Serracarbassa

7

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Caio V Regatieri

8

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Rubens Belfort

9

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

publication date

1 May 2017

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

International Journal of Retina and Vitreous

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

3

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

6

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

copyright license

Creative Commons Attribution 4.0 International

1 May 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Monitoring ocular drug therapy by analysis of aqueous samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Vascular endothelial growth factor expression in choroidal neovascularization in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

https://api.crossref.org/works/10.1186%2FS40942-017-0066-Y

21 January 2018

Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

22 May 2018

Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Clinicopathologic correlation of retinal angiomatous proliferation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

Causes and prevalence of visual impairment among adults in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410688

13 August 2018

The effect of methotrexate on corneal neovascularization in rabbits

1 reference

https://api.crossref.org/works/10.1186%2FS40942-017-0066-Y

21 January 2018

Hypoxic regulation of vascular endothelial growth factor in retinal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of Growth Factors in Subfoveal Neovascular Membranes in Age-related Macular Degeneration and Presumed Ocular Histoplasmosis Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28469938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S40942-017-0066-Y

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 May 2018

http://europepmc.org/abstract/PMC/5410688

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53315137&oldid=2212074045"